| Median survival months | 2-yr survival % | p-value | |
| Site | |||
| Pleural | 8.1 | 13 | <0.001 |
| Peritoneal | 3.9 | 13 | |
| Tumour type | |||
| Not specified | 6.1 | 11 | <0.001 |
| Sarcomatoid | 3.6 | 8 | |
| Epitheloid | 10.1 | 16 | |
| Mixed | 7.1 | 9 | |
| Sex | |||
| Males | 7.7 | 13 | 0.073 |
| Females | 8.1 | 15 | |
| Age yrs | |||
| 20–59 | 10.5 | 19 | <0.001 |
| 60–69 | 9.0 | 14 | |
| 70–79 | 6.5 | 10 | |
| ≥80 | 5.2 | 6 | |
| No chemotherapy | |||
| 1995–1998 | 6.8 | 11 | 0.125 |
| 1999–2002 | 7.3 | 13 | |
| 2003–2004 | 6.2 | 11 | |
| 2005–2006 | 7.1 | 11 | |
| Chemotherapy | |||
| 1995–1998 | 10.1 | 16 | 0.002 |
| 1999–2002 | 11.9 | 17 | |
| 2003–2004 | 12.7 | 19 | |
| 2005–2006 | 13.3 | 22 |